Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat
Xue Bai1, Zhigang Bian2, Meng Zhang1
1Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, 110004, Shenyang, Liaoning, PR China.
Background:
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a classical nuclear transcription factor that regulates the system's anti-oxidative stress response. The activation of Nrf2 induces the expression of antioxidant proteins and improves the system's anti-oxidative stress ability. Accumulating evidence suggests that Nrf2-centered signaling pathways may be a key pharmacological target for the treatment of neurodegenerative diseases (NDDs). However, phytochemicals as new therapeutic agents against NDDs have not been clearly delineated.
Purpose:
To review the therapeutic effects of phytochemical ingredients on NDDs by activating Nrf2 and reducing oxidative stress injury.
Methods:
A comprehensive search of published articles was performed using various literature databases including PubMed, Google Scholar, and China National Knowledge Infrastructure. The search terms included "Nrf2", "phytochemical ingredients", "natural bioactive agents", "neurodegenerative diseases", "Antioxidant", "Alzheimer's disease", "Parkinson's disease", "Huntington's disease", "amyotrophic lateral sclerosis" "multiple sclerosis", "toxicity", and combinations of these keywords. A total of 769 preclinical studies were retrieved until August 2022, and we included 39 of these articless on phytochemistry, pharmacology, toxicology and other fields.
Results:
Numerous in vivo and in vitro studies showed that phytochemical ingredients could act as an Nrf2 activator in the treatment of NDDs through the antioxidant defense mechanism. These phytochemical ingredients, such as salidroside, naringenin, resveratrol, sesaminol, ellagic acid, ginsenoside Re, tanshinone I, sulforaphane, curcumin, naringin, tetramethylpyrazine, withametelin, magnolol, piperine, and myricetin, had the potential to improve Nrf2 signaling, thereby combatting NDDs.
Conclusion:
As Nrf2 activators, phytochemical ingredients may provide a novel potential strategy for the treatment of NDDs. Here, we reviewed the interaction between phytochemical ingredients, Nrf2, and its antioxidant damaging pathway in NDDs and explored the advantages of phytochemical ingredients in anti-oxidative stress, which provides a reliable basis for improving the treatment of NDDs. However, further clinical trials are needed to determine the safety and efficacy of Nrf2 activators for NDDs.
Insights
Phytochemicals activate Nuclear factor erythroid 2-related factor 2 (Nrf2) to combat oxidative stress in neurodegenerative diseases (NDDs). These natural compounds show promise for NDD treatment, but clinical trials are needed.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular antioxidant responses.
- Nrf2-mediated pathways are critical targets for treating neurodegenerative diseases (NDDs).
- The therapeutic potential of phytochemicals in NDDs via Nrf2 activation requires further elucidation.
Purpose of the Study:
- To review the therapeutic effects of phytochemicals on NDDs.
- To examine the role of Nrf2 activation and oxidative stress reduction.
- To assess phytochemicals as potential agents against neurodegeneration.
Main Methods:
- Comprehensive literature search of PubMed, Google Scholar, and CNKI databases.
- Keywords included "Nrf2", "phytochemical ingredients", "neurodegenerative diseases", and specific NDDs.
- Analysis of 769 retrieved preclinical studies, with 39 selected for review.
Main Results:
- Phytochemicals activate Nrf2, enhancing antioxidant defense mechanisms against NDDs.
- Specific phytochemicals like resveratrol, curcumin, and sulforaphane show promise.
- These compounds improve Nrf2 signaling, offering a potential therapeutic avenue.
Conclusions:
- Phytochemicals acting as Nrf2 activators represent a novel strategy for NDD treatment.
- Understanding the phytochemical-Nrf2 interaction provides a basis for improved NDD therapies.
- Further clinical trials are essential to validate the safety and efficacy of these Nrf2 activators.
More Related Videos
09:02Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
09:17Assessing Neurodegenerative Phenotypes in Drosophila Dopaminergic Neurons by Climbing Assays and Whole Brain Immunostaining
Published on: April 24, 2013
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
